Camurus’ second CRL for acromegaly drug; Teva details workforce cuts

June 11, 2026 10:45 AM EDTUpdated 11:04 AM Manufacturing Ca­mu­rus’ sec­ond CRL for acromegaly drug; Te­va de­tails work­force cuts Ayisha Sharma News Reporter Plus, news about a drug short­ages re­port and Ax­plo­ra: 🛑 Ca­mu­rus has been hit with a sec­ond CRL: The re­jec­tion is for the drug CAM2029 … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER